Is VMTHF or DIVO a better dividend investment in 2026?

VMTHF currently yields 474.05% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: VMTHF offers higher current income.

What is the dividend yield difference between VMTHF and DIVO?

VMTHF has a forward dividend yield of 474.05% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 467.43 percentage points.

Home › Compare › VMTHF vs DIVO

VMTHF vs DIVO: Dividend Comparison 2026

VMTHF yields 474.05% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VMTHF wins by $40760.08M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VMTHF

● Live price

474.05%

Share price

$0.42

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40760.11M

Annual income

$28,806,329,273.60

Full VMTHF calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — VMTHF vs DIVO

📍 VMTHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VMTHF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VMTHF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VMTHF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VMTHF

Annual income on $10K today (after 15% tax)

$40,293.91/yr

After 10yr DRIP, annual income (after tax)

$24,485,379,882.56/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, VMTHF beats the other by $24,485,379,025.36/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VMTHF + DIVO for your $10,000?

VMTHF: 50%DIVO: 50%

100% DIVO50/50100% VMTHF

Portfolio after 10yr

$20380.07M

Annual income

$14,403,165,141.04/yr

Blended yield

70.67%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VMTHF buys

DIVO buys

No recent congressional trades found for VMTHF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVMTHFDIVO

Forward yield	474.05% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$40760.11M ✓	$31.0K
Annual income after 10y	$28,806,329,273.60 ✓	$1,008.47
Total dividends collected	$39707.63M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: VMTHF vs DIVO ($10,000, DRIP)

Year	VMTHF Portfolio	VMTHF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$58,105	$47,404.60	$11,362	$661.96	+$46.7K → VMTHF
2	$319,595	$257,422.91	$12,860	$702.91	+$306.7K → VMTHF
3	$1,665,249	$1,323,282.78	$14,504	$743.56	+$1.65M → VMTHF
4	$8,225,711	$6,443,893.93	$16,303	$783.73	+$8.21M → VMTHF
5	$38,549,580	$29,748,069.43	$18,268	$823.31	+$38.53M → VMTHF
6	$171,541,094	$130,293,043.94	$20,408	$862.17	+$171.52M → VMTHF
7	$725,407,583	$541,858,612.30	$22,737	$900.20	+$725.38M → VMTHF
8	$2,917,676,445	$2,141,490,330.46	$25,266	$937.31	+$2917.65M → VMTHF
9	$11,171,756,198	$8,049,842,402.84	$28,008	$973.42	+$11171.73M → VMTHF
10	$40,760,108,406	$28,806,329,273.60	$30,977	$1,008.47	+$40760.08M → VMTHF

VMTHF vs DIVO: Complete Analysis 2026

VMTHF — Stock

Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.

Full VMTHF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this VMTHF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VMTHF vs SCHD VMTHF vs JEPI VMTHF vs O VMTHF vs KO VMTHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.